In animal studies, Zn supplementation in rats with diet-induced NAFLD was found to reduce the severity of hepatic steatosis in periportal areas, reduce lipid deposition in hepatocytes, improve glucose metabolism and insulin signalling, and reduce liver damage [66,67,68]. The gene discussed is INS; the disease is fatty liver disease.